{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T21:37:43Z","timestamp":1648935463381},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00261-018-1834-3","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T11:00:05Z","timestamp":1544094005000},"page":"1152-1154","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Caveat regarding CMS Merit-based Incentive Payment Systems incidental adrenal nodule measure"],"prefix":"10.1007","volume":"44","author":[{"given":"Joseph","family":"Holman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot K.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela T.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"key":"1834_CR1","unstructured":"Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions\u2013 National Quality Strategy Domain: Effective Clinical Care \n                    https:\/\/qpp.cms.gov\/docs\/QPP_quality_measure_specifications\/Claims-Registry-Measures\/2017_Measure_405_Claims.pdf\n                    \n                  . Accessed 5 Aug 5 2018"},{"key":"1834_CR2","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jacr.2017.05.001","volume":"14","author":"WW Mayo-Smith","year":"2017","unstructured":"Mayo-Smith WW, Song JH, Boland GL, et al. (2017) Management of incidental adrenal masses:\u00a0a white paper of the ACR incidental findings committee. J Am Coll Radiol. 14:1038\u20131044","journal-title":"J Am Coll Radiol."},{"issue":"5","key":"1834_CR3","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/RCT.0b013e31829cbecf","volume":"37","author":"AR Oshmyansky","year":"2013","unstructured":"Oshmyansky AR, Mahammedi A, Dackiw A, et al. (2013) Serendipity in the diagnosis of pheochromocytoma. J Comput Assist Tomogr. 37(5):820\u2013823","journal-title":"J Comput Assist Tomogr."},{"key":"1834_CR4","doi-asserted-by":"publisher","first-page":"684","DOI":"10.2214\/ajr.185.3.01850684","volume":"185","author":"GA Motta-Ramierz","year":"2005","unstructured":"Motta-Ramierz GA, Remer EM, Herts BR, Gill IS, Hamrahian AH (2005) Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. AJR 185:684","journal-title":"AJR"},{"issue":"2","key":"1834_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1530\/EJE-09-0384","volume":"161","author":"R Kopetschke","year":"2009","unstructured":"Kopetschke R, Slisko M, Kilisli A, et al. (2009) Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. Eur J Endocrinol. 161(2):355\u2013361","journal-title":"Eur J Endocrinol."},{"key":"1834_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/00000658-199906000-00001","volume":"229","author":"RE Goldstein","year":"1999","unstructured":"Goldstein RE, O\u2019Neill JA, Holcomb GW, et al. (1999) Clinical experience over 48\u00a0years with pheochromocytoma. Ann Surg. 229:755","journal-title":"Ann Surg."},{"key":"1834_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.2214\/AJR.12.9753","volume":"201","author":"BG Northcutt","year":"2013","unstructured":"Northcutt BG, Raman S, Long CM, et al. (2013) MDCT of adrenal masses: can dual-phase enhancement patterns be used to distinguish between adenoma and pheochromocytoma. AJR 201:834\u2013839","journal-title":"AJR"},{"key":"1834_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/RCT.0000000000000343","volume":"40","author":"BG Northcutt","year":"2016","unstructured":"Northcutt BG, Trakhtenbroit MA, Gomez EN, Fishman EK, Johnson PT (2016) Adrenal adenoma and pheochromocytoma: comparison of multidetector CT venous enhancement levels and washout characteristics. J Comput Assist Tomogr. 40:194\u2013200","journal-title":"J Comput Assist Tomogr."},{"key":"1834_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.carj.2014.01.001","volume":"65","author":"M Stamm","year":"2014","unstructured":"Stamm M, Abele JT (2014) Streamlining the imaging of clinically suspected pheochromocytoma: using urine metanephrines to decrease imaging costs. Can Assoc Radiol J. 65:372\u2013378","journal-title":"Can Assoc Radiol J."},{"key":"1834_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1210\/jc.2002-021251","volume":"88","author":"AM Sawka","year":"2003","unstructured":"Sawka AM, Jaeschke R, Singh RJ, Young WF Jr (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab. 88:553\u2013558","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-018-1834-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-018-1834-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-018-1834-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:04:54Z","timestamp":1575590694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-018-1834-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1834"],"URL":"https:\/\/doi.org\/10.1007\/s00261-018-1834-3","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,6]]},"assertion":[{"value":"6 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Joseph Holman and Roberto Salvatori have nothing to disclosures. Elliot K. Fishman received grant funding from GE Healthcare and Siemens and Founder and stockholder of HipGraphics. Pamela T. Johnson is a Consultant to Oliver Wyman.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}